CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
53,14
04-октября-24 15:59:59
15 мин. задержка
Акции
+0,37
+0,70%
Сегодняшний диапазон
52,73 - 53,59
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
13 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 окт 2022 16:57:25 Источник Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
08 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
06 сен 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
02 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
12 авг 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 авг 2022 16:44:12 Источник Nasdaq GlobeNewswire
-
04 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 июл 2022 17:09:22 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 июн 2022 16:30:47 Источник Nasdaq GlobeNewswire
-
Crinetics Presents Clinical and Research Results at ENDO 2022
08 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
07 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
25 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
12 май 2022 16:41:57 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 май 2022 16:18:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
18 апр 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
12 апр 2022 23:52:43 Источник Nasdaq GlobeNewswire